Roles of naïve CD4 + T cells and their differentiated subtypes in lung adenocarcinoma and underlying potential regulatory pathways
Liu, Runze, Yang, Guangjian, Guo, Hongbo, Chen, Feihu, Lu, Shuangqing, Zhu, Hui
Published in Journal of translational medicine (22.08.2024)
Published in Journal of translational medicine (22.08.2024)
Get full text
Journal Article
Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2)
Yang, Guangjian, Xu, Haiyan, Yang, Yaning, Zhang, Shuyang, Xu, Fei, Hao, Xuezhi, Li, Junling, Xing, Puyuan, Hu, Xingsheng, Liu, Yutao, Wang, Lin, Lin, Lin, Wang, Zhijie, Duan, Jianchun, Wang, Jie, Wang, Yan
Published in BMC medicine (29.08.2022)
Published in BMC medicine (29.08.2022)
Get full text
Journal Article
EGFR exon 20 insertion variants A763_Y764insFQEA and D770delinsGY confer favorable sensitivity to currently approved EGFR-specific tyrosine kinase inhibitors
Yang, Guangjian, Yang, Yaning, Hu, Jiaqi, Xu, Haiyan, Zhang, Shuyang, Wang, Yan
Published in Frontiers in pharmacology (08.11.2022)
Published in Frontiers in pharmacology (08.11.2022)
Get full text
Journal Article
Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer
Yin, Xiaoyan, Zhu, Wanqi, Tang, Xiaoyong, Yang, Guangjian, Zhao, Xianguang, Zhao, Kaikai, Jiang, Liyang, Li, Xiaolin, Zhao, Hong, Wang, Xin, Yan, Yuanyuan, Xing, Ligang, Yu, Jinming, Meng, Xiangjiao, Zhao, Hanxi
Published in BMC cancer (17.04.2024)
Published in BMC cancer (17.04.2024)
Get full text
Journal Article
First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for HER2-altered NSCLC: a retrospective real-world POLISH study
Yang, Guangjian, Yang, Yaning, Liu, Runze, Li, Weihua, Xu, Haiyan, Hao, Xuezhi, Li, Junling, Xing, Puyuan, Zhang, Shuyang, Ai, Xin, Xu, Fei, Wang, Yan
Published in Therapeutic advances in medical oncology (2022)
Published in Therapeutic advances in medical oncology (2022)
Get full text
Journal Article
EGFR uncommon alterations in advanced non-small cell lung cancer and structural insights into sensitivity to diverse tyrosine kinase inhibitors
Xu, Haiyan, Yang, Guangjian, Liu, Runze, Yang, Yaning, Li, Weihua, Li, Junling, Hao, Xuezhi, Xing, Puyuan, Wang, Yan
Published in Frontiers in pharmacology (16.09.2022)
Published in Frontiers in pharmacology (16.09.2022)
Get full text
Journal Article
Organ-specific immune checkpoint inhibitor treatment in lung cancer: a systematic review and meta-analysis
Yu, Shufei, Zhang, Shuyang, Xu, Haiyan, Yang, Guangjian, Xu, Fei, Yang, Liang, Chen, Duo, An, Guangyu, Wang, Yan
Published in BMJ open (17.03.2023)
Published in BMJ open (17.03.2023)
Get full text
Journal Article
Concomitant TP53 mutations with response to crizotinib treatment in patients with ALK‐rearranged non‐small‐cell lung cancer
Song, Peng, Zhang, Fanshuang, Li, Yan, Yang, Guangjian, Li, Wenbin, Ying, Jianming, Gao, Shugeng
Published in Cancer medicine (Malden, MA) (01.04.2019)
Published in Cancer medicine (Malden, MA) (01.04.2019)
Get full text
Journal Article
Treatment outcome and clinical characteristics of HER2 mutated advanced non‐small cell lung cancer patients in China
Xu, Fei, Yang, Guangjian, Xu, Haiyan, Yang, Lu, Qiu, Weini, Wang, Yan
Published in Thoracic cancer (01.03.2020)
Published in Thoracic cancer (01.03.2020)
Get full text
Journal Article
Clinical and structural insights into the rare but oncogenic HER2-activating missense mutations in non-small cell lung cancer: a retrospective ATLAS cohort study
Yang, Guangjian, Liu, Runze, Li, Pei, Yang, Yaning, Wang, Yajie, Mao, Huiqing, Tang, Xiaoyong
Published in Discover. Oncology (16.07.2024)
Published in Discover. Oncology (16.07.2024)
Get full text
Journal Article
EGFR Exon 18 Mutations in Advanced Non-Small Cell Lung Cancer: A Real-World Study on Diverse Treatment Patterns and Clinical Outcomes
Xu, Haiyan, Yang, Guangjian, Li, Weihua, Li, Junling, Hao, Xuezhi, Xing, Puyuan, Yang, Yaning, Wang, Yan
Published in Frontiers in oncology (02.09.2021)
Published in Frontiers in oncology (02.09.2021)
Get full text
Journal Article
Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas harboring KRAS and BRCA mutations: case report and whole exome sequencing analysis
Yang, Guangjian, Yin, Jiangxia, Ou, Kai, Du, Qiang, Ren, Wenhao, Jin, Yujing, Peng, Liming, Yang, Lin
Published in BMC gastroenterology (26.06.2020)
Published in BMC gastroenterology (26.06.2020)
Get full text
Journal Article
Heterogeneous Response to First-Generation Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancers with Different EGFR Exon 19 Mutations
Xu, Haiyan, Li, Weihua, Yang, Guangjian, Li, Junling, Yang, Lu, Xu, Fei, Yang, Yaning, Ying, Jianming, Wang, Yan
Published in Targeted oncology (01.06.2020)
Published in Targeted oncology (01.06.2020)
Get full text
Journal Article
The efficacy and safety of chemo‐free therapy in epidermal growth factor receptor tyrosine kinase inhibitor‐resistant advanced non‐small cell lung cancer: A single‐arm, phase II study
Zhang, Shuyang, Yang, Lu, Yang, Yaning, Yang, Guangjian, Xu, Haiyan, Niu, Xueliang, Wang, Yan
Published in Cancer medicine (Malden, MA) (01.10.2023)
Published in Cancer medicine (Malden, MA) (01.10.2023)
Get full text
Journal Article
The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase Inhibitors
Yang, Guangjian, Liu, Chengming, Hu, Jiaqi, Sun, Yang, Hu, Peizeng, Liu, Liu, Xu, Haiyan, Li, Dazhou, Li, Weihua, Yang, Yaning, Sun, Nan, He, Jie, Wang, Yan
Published in Frontiers in oncology (11.02.2022)
Published in Frontiers in oncology (11.02.2022)
Get full text
Journal Article
Possibility of brigatinib‐based therapy, or chemotherapy plus anti‐angiogenic treatment after resistance of osimertinib harboring EGFR T790M‐cis‐C797S mutations in lung adenocarcinoma patients
Yang, Yaning, Xu, Haiyan, Ma, Li, Yang, Lu, Yang, Guangjian, Zhang, Shuyang, Ai, Xin, Zhang, Shucai, Wang, Yan
Published in Cancer medicine (Malden, MA) (01.12.2021)
Published in Cancer medicine (Malden, MA) (01.12.2021)
Get full text
Journal Article
A Linear Discriminant Analysis Model Based on the Changes of 7 Proteins in Plasma Predicts Response to Anlotinib Therapy in Advanced Non-Small Cell Lung Cancer Patients
Xu, Fei, Xu, Haiyan, Wan, Zhiyi, Yang, Guangjian, Yang, Lu, Wu, Xueying, Song, Jin, Wang, Yan
Published in Frontiers in oncology (07.01.2022)
Published in Frontiers in oncology (07.01.2022)
Get full text
Journal Article